Cargando…

Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis

Mucopolysaccharidoses (MPS) are genetic metabolic diseases characterized by defects in the activity of lysosomal hydrolases. In MPS, secondary cell disturbance affects pathways related to cardiovascular disorders. Hence, the study aimed to identify MPS-related drugs targeting cardiovascular disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villalba Silva, Gerda Cristal, Steindorff, Thiago, Silvestri Schuh, Roselena, Cardoso Flores, Natalia, Matte, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784427/ https://www.ncbi.nlm.nih.gov/pubmed/36556450 http://dx.doi.org/10.3390/life12122085

Ejemplares similares

Factors influencing transfection efficiency of pIDUA/nanoemulsion complexes in a mucopolysaccharidosis type I murine model
por: Fraga, Michelle, et al.
Publicado: (2017)

Fantastic databases and where to find them: Web applications for researchers in a rush
por: Villalba, Gerda Cristal, et al.
Publicado: (2021)

Mucopolysaccharidosis Type I
por: Kubaski, Francyne, et al.
Publicado: (2020)

Applying the functional independence measure to the assessment of patients with mucopolysaccharidosis
por: Almeida Matos, Marcos, et al.
Publicado: (2020)

Comment on “report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I”
por: Poletto, Edina, et al.
Publicado: (2018)

A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma
por: Lotfi Shahreza, Maryam, et al.
Publicado: (2020)

Network determinants of cardiovascular calcification and repositioned drug treatments
por: Song, Euijun, et al.
Publicado: (2020)

Effects of Enzyme Replacement Therapy Started Late in a Murine Model of Mucopolysaccharidosis Type I
por: Pasqualim, Gabriela, et al.
Publicado: (2015)

In silico analysis of potential off-target sites to gene editing for Mucopolysaccharidosis type I using the CRISPR/Cas9 system: Implications for population-specific treatments
por: Carneiro, Paola, et al.
Publicado: (2022)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease
por: Montavon, Brittany, et al.
Publicado: (2022)

Characterization of the 3'UTR of the BTD gene and identification of regulatory elements and microRNAs
por: Silva, Gerda Cristal Villalba, et al.
Publicado: (2022)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

Drug Repositioning for Hand, Foot, and Mouth Disease
por: Yan, Ran, et al.
Publicado: (2022)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Biochemical diagnosis of mucopolysaccharidosis in a Mexican reference center
por: Mendoza-Ruvalcaba, Sandra del Carmen, et al.
Publicado: (2020)

Autofocus Entropy Repositioning Method Bioinspired in the Magnetic Field Memory of the Bees Applied to Pollination
por: dos Santos, Daniel de Matos Luna, et al.
Publicado: (2021)

Drug repositioning: Progress and challenges in drug discovery for various diseases
por: Hua, Yi, et al.
Publicado: (2022)

Concept Modeling-based Drug Repositioning
por: Patchala, Jagadeesh, et al.
Publicado: (2015)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Changing Trends in Computational Drug Repositioning
por: Yella, Jaswanth K., et al.
Publicado: (2018)

Review of Drug Repositioning Approaches and Resources
por: Xue, Hanqing, et al.
Publicado: (2018)

The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017)

Thiopurine Drugs Repositioned as Tyrosinase Inhibitors
por: Choi, Joonhyeok, et al.
Publicado: (2017)

A standard database for drug repositioning
por: Brown, Adam S., et al.
Publicado: (2017)

Repositioning Natural Products in Drug Discovery
por: Rastelli, Giulio, et al.
Publicado: (2020)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

Topological network measures for drug repositioning
por: Badkas, Apurva, et al.
Publicado: (2020)

Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022)

Microalbuminuria en pacientes con diabetes mellitus tipo 2 de 10 años de evolución
por: Bello Ramírez, Roselena
Publicado: (2001)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Drug repositioning, a new alternative in infectious diseases
por: Serafin, Marissa Bolson, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pa3s2fq6sl1uulp1m9o1omsndg